MedPath
HSA Approval

GLYCOPHOS CONCENTRATE FOR SOLUTION FOR INFUSION 216 mg/ml

SIN11858P

GLYCOPHOS CONCENTRATE FOR SOLUTION FOR INFUSION 216 mg/ml

GLYCOPHOS CONCENTRATE FOR SOLUTION FOR INFUSION 216 mg/ml

April 1, 2002

FRESENIUS KABI (SINGAPORE) PTE LTD

FRESENIUS KABI (SINGAPORE) PTE LTD

Regulatory Information

FRESENIUS KABI (SINGAPORE) PTE LTD

FRESENIUS KABI (SINGAPORE) PTE LTD

Therapeutic

General Sale List

Formulation Information

INJECTION

**DOSAGE AND ADMINISTRATION** Glycophos must not be given undiluted. **Adults:** The recommended dosage is individual. The recommended daily dosage of phosphate during intravenous nutrition would normally be 10 –20 mmol. This can be met by using 10 –20 ml of Glycophos added to the infusion solution or to the admixture for which compatibility has been proved.

INTRAVENOUS

Medical Information

**INDICATIONS** Glycophos is indicated in adult patients as a supplement in intravenous nutrition to meet the requirement of phosphate.

**CONTRAINDICATIONS** - state of dehydration, - hypernatraemia, - hyperphosphataemia, - severe renal insufficiency, - shock.

B05XA14

sodium glycerophosphate

Manufacturer Information

FRESENIUS KABI (SINGAPORE) PTE LTD

FRESENIUS KABI NORGE AS

Active Ingredients

SODIUM GLYCEROPHOSPHATE (ANHYDROUS)

216 mg/ml

Documents

Package Inserts

Glycophos Concentrate For Solution For Infusion PI.pdf

Approved: July 17, 2020

Download
© Copyright 2025. All Rights Reserved by MedPath